Home Cart 0 Sign in  

[ CAS No. 84110-34-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 84110-34-9
Chemical Structure| 84110-34-9
Structure of 84110-34-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 84110-34-9 ]

Related Doc. of [ 84110-34-9 ]

Alternatived Products of [ 84110-34-9 ]

Product Details of [ 84110-34-9 ]

CAS No. :84110-34-9 MDL No. :MFCD09837626
Formula : C14H25BO2 Boiling Point : -
Linear Structure Formula :- InChI Key :QGWQMLAZUPRXGK-FMSGJZPZSA-N
M.W : 236.16 Pubchem ID :12842239
Synonyms :

Calculated chemistry of [ 84110-34-9 ]

Physicochemical Properties

Num. heavy atoms : 17
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 71.83
TPSA : 18.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.91 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 3.98
Log Po/w (WLOGP) : 3.37
Log Po/w (MLOGP) : 2.63
Log Po/w (SILICOS-IT) : 1.96
Consensus Log Po/w : 2.39

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.68
Solubility : 0.0494 mg/ml ; 0.000209 mol/l
Class : Soluble
Log S (Ali) : -4.07
Solubility : 0.0202 mg/ml ; 0.0000853 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -3.02
Solubility : 0.228 mg/ml ; 0.000964 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 4.95

Safety of [ 84110-34-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 84110-34-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 84110-34-9 ]
  • Downstream synthetic route of [ 84110-34-9 ]

[ 84110-34-9 ] Synthesis Path-Upstream   1~5

  • 1
  • [ 84110-40-7 ]
  • [ 57022-61-4 ]
  • [ 84110-34-9 ]
YieldReaction ConditionsOperation in experiment
97.2% at 20℃; for 23 h; A reaction mixture containing (+)-pinanediol (6.9 g) and 2-methylpropylboronic acid (4.4 g) and diethylether (49.3 ml) was stirred for 23 hours at laboratory temperature, than dried over Na2SO4 (16.5 g). The sulfate was filtered off and washed with diethylether (69.4 ml), and the resulting solution was concentrated. The product was obtained as colorless oil (9.9 g, purity 100 percent (GC), yield 97.2 percent). MS (m/z): 236, 221, 195, 167, 140, 134, 83, 67, 55, 43; 1H- NMR (DMSO-d6): δ= 4.27 (IH, dd, J=2.1 Hz, 8.7 Hz); 2.30 (IH, m); 2.18 (IH, m); 1.96 (IH, t, J=5.4 Hz); 1.86 (IH, m); 1.79 (IH, sx, J-6.8 Hz); 1.69 (IH, m); 1.30 (3H, s); 1.25 (3H, s); 1.02 (IH, d, J=I 0.6 Hz); 0.9 (3H, d, J-6.6 Hz); 0.81 (3H, s); 0.69 (2H, m)).
Reference: [1] Patent: WO2009/4350, 2009, A1, . Location in patent: Page/Page column 9
[2] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 4, p. 1018 - 1029
  • 2
  • [ 84110-40-7 ]
  • [ 18680-27-8 ]
  • [ 84110-34-9 ]
YieldReaction ConditionsOperation in experiment
95% at 40℃; for 8 h; The (+) – Pinanediol (17.0g,0.10mol) with 2-methylpropylBoric acid(11.2g,0.11mol) sequentially added into 200ml of Ethylene ether then themixture was heated to 40 ° C, stirred for 8 hours; after Completion of thereaction, the mixture was dried using anhydrous magnesium sulfate; filtrated;The filtrate was concentrated under reduced pressure to dryness; With 200mLisopropyl ether beating of the reaction for  two hours; again filteredthen filtrate was concentrated under reduced pressure to dryness to obtainformula 3 compound 22.4g (0.095mol, Molar yield 95percent).
94% at 20℃; for 24 h; A mixture of (+) -pinanediol (23.9 g, 0.140 mol) and 2- methylpropylboronic acid (15 g, 0.147 mol) in diethyl ether (300 ml) was stirred at room temperature for 24h. The mixture was dried over anhydrous sodium sulfate and purified by column chromatography (Silica gel 230-400 mesh), eluting with hexane: ethyl acetate 90: 10 mixture. The product was obtained as a clear oil (32.6 g, 94percent yield). 1H NMR (DMSO-d6) : 4. 28 (1H, dd, J=8.8 Hz, 2.0) ; 2.30 (1H, M) ; 2.18 (1H, M) ; 1.96 (1H, t, J=5.3) ; 1.86 (1H, M) ; 1.78 (1H, set, J=6.8) ; 1.68 (1H, M) ; 1.30 (3H, s); 1.25 (3H, s); 1.01 (1H, d); 0.9 (6H, d, J=6.6) ; 0.81 (3H, s); 0.69 (2H, M).
94% at 20℃; for 24 h; A mixture of (+)-pinanediol (23.9 g, 0.140 mol) and 2-methylpropylboronic acid (15 g, 0.147 mol) in diethyl ether (300 ml) was stirred at room temperature for 24 h.
The mixture was dried over anhydrous sodium sulfate and purified by column chromatography (Silica gel 230-400 mesh), eluding with hexane:ethyl acetate 90:10 mixture.
The product was obtained as a clear oil (32.6 g, 94percent yield).
1H NMR (DMSO-d6): 4.28 (1H, dd, J=8.8 Hz, 2.0); 2.30 (1H, m); 2.18 (1H, m); 1.96 (1H, t, J=5.3); 1.86 (1H, m); 1.78 (1H, set, J=6.8); 1.68 (1H, m); 1.30 (3H, s); 1.25 (3H, s); 1.01 (1H, d); 0.9 (6H, d, J=6.6); 0.81 (3H, s); 0.69 (2H, m).
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 12, p. 3220 - 3224
[2] Patent: CN103421033, 2016, B, . Location in patent: Paragraph 0047-0050
[3] Tetrahedron, 2007, vol. 63, # 28, p. 6577 - 6586
[4] Patent: WO2005/21558, 2005, A2, . Location in patent: Page/Page column 52
[5] Patent: US2006/189806, 2006, A1, . Location in patent: Page/Page column 29
[6] Journal of Medicinal Chemistry, 2008, vol. 51, # 4, p. 1068 - 1072
[7] Journal of Organic Chemistry, 2010, vol. 75, # 2, p. 468 - 471
[8] Chemistry Letters, 2009, vol. 38, # 7, p. 750 - 751
[9] Organometallics, [10] Organometallics, 1983, vol. 2, p. 236 - 241
[11] Bioorganic and Medicinal Chemistry Letters, 2002, vol. 12, # 21, p. 3199 - 3202
[12] Journal of Labelled Compounds and Radiopharmaceuticals, 2007, vol. 50, # 5-6, p. 402 - 406
[13] Patent: WO2009/36281, 2009, A2, . Location in patent: Page/Page column 33
[14] Chemistry Letters, 2009, vol. 38, # 7, p. 750 - 751
[15] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 8, p. 1958 - 1962
  • 3
  • [ 926-62-5 ]
  • [ 819816-59-6 ]
  • [ 84110-34-9 ]
YieldReaction ConditionsOperation in experiment
62%
Stage #1: at -78 - 20℃;
Stage #2: With sulfuric acid In tetrahydrofuran; diethyl ether; di-isopropyl ether; water at 20℃; for 0.166667 h;
A 2M solution of isobutyl magnesium bromide in diethyl ether (131.5 ml, 0.263 mol) was added dropwise, in 1 hour, to a solution of 2- (1-METHYLETHOXY)- (3aS, 4S, 6S, 7aR) -hexahydro-3a, 5,5-trimethyl-4, 6-methano-1, 3, 2-benzodioxaborole obtained in Step 1 (62.6 g, 0.263 mol), in anhydrous tetrahydrofuran (330 ml) while stirring AT-78°C, under nitrogen. The mixture was then allowed to warm to room temperature, then transferred in a mixture OF 2N sulfuric acid (150 ml) and diisopropyl ether (250 ml). After stirring for 10 minutes, a saturated solution OF NACI was added (100 ml) and the layers were separated. The organic phase was washed with brine (100 ml), dried over sodium sulfate and concentrated. The residue was purified by column chromatography (silica gel) eluting with 5percent diethyl ether in hexane. The product was obtained as a clear oil (38.45 g, 62percent yield).
62%
Stage #1: With sulfuric acid In tetrahydrofuran; diethyl ether at -78 - 20℃;
Stage #2: With sulfuric acid In tetrahydrofuran; diethyl ether; di-isopropyl ether; water at 20℃; for 0.166667 h;
A 2M solution of isobutyl magnesium bromide in diethyl ether (131.5 ml, 0.263 mol) was added dropwise, in 1 hour, to a solution of 2-(1-methylethoxy)-(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborole obtained in Step 1 (62.6 g, 0.263 mol), in anhydrous tetrahydrofuran (330 ml) while stirring at -78° C., under nitrogen.
The mixture was then allowed to warm to room temperature, then transferred in a mixture of 2N sulfuric acid (150 ml) and diisopropyl ether (250 ml).
After stirring for 10 minutes, a saturated solution of NaCl was added (100 ml) and the layers were separated.
The organic phase was washed with brine (100 ml), dried over sodium sulfate and concentrated.
The residue was purified by column chromatography (silica gel) eluding with 5percent diethyl ether in hexane.
The product was obtained as a clear oil (38.45 g, 62percent yield).
Reference: [1] Patent: WO2005/21558, 2005, A2, . Location in patent: Page/Page column 55-56
[2] Patent: US2006/189806, 2006, A1, . Location in patent: Page/Page column 30
  • 4
  • [ 593-71-5 ]
  • [ 90084-26-7 ]
  • [ 84110-34-9 ]
Reference: [1] Organometallics, [2] Organometallics, 1985, vol. 4, p. 1687 - 1689
  • 5
  • [ 7785-70-8 ]
  • [ 84110-34-9 ]
Reference: [1] Tetrahedron, 2007, vol. 63, # 28, p. 6577 - 6586
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 84110-34-9 ]

Organoboron

Chemical Structure| 87100-15-0

[ 87100-15-0 ]

2-Cyclohexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.84

Chemical Structure| 69190-62-1

[ 69190-62-1 ]

2-Butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.84

Chemical Structure| 126689-01-8

[ 126689-01-8 ]

2-Cyclopropyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.80

Chemical Structure| 76347-13-2

[ 76347-13-2 ]

2-Isopropyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.77

Chemical Structure| 1131912-76-9

[ 1131912-76-9 ]

4,4,5,5-Tetramethyl-2-(tetrahydro-2H-pyran-4-yl)-1,3,2-dioxaborolane

Similarity: 0.76

Related Parent Nucleus of
[ 84110-34-9 ]

Other Aliphatic Heterocycles

Chemical Structure| 779357-85-6

[ 779357-85-6 ]

(R)-BoroLeu-(+)-Pinanediol hydrochloride

Similarity: 0.76

Chemical Structure| 179324-87-9

[ 179324-87-9 ]

(R)-3-Methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butan-1-amine 2,2,2-trifluoroacetate

Similarity: 0.60

Chemical Structure| 230299-17-9

[ 230299-17-9 ]

(3aR,3'aR,4R,4'R,6R,6'R,7aS,7'aS)-Dodecahydro-3a,3'a,5,5,5',5'-hexamethyl-2,2'-bi-4,6-methano-1,3,2-benzodioxaborole

Similarity: 0.57

Chemical Structure| 862129-81-5

[ 862129-81-5 ]

2-(3,6-Dihydro-2H-thiopyran-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Similarity: 0.53